In our ELISA‐based analysis of HNSCC, a CD109 level above the cut‐off value (preoperative CD109 level of 38.0 ng/ml and CD109 index of 1.6) was associated with a poor prognosis and lymph node metastasis. Here, CD109 is linked to head and neck squamous cell carcinoma.